Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection Preservative Free NDC 71384-640-
Recalled October 11, 2023 · FDA recall D-0040-2024 · Imprimis NJOF
Hazard
Subpotent: Failing Test Results for Epinephrine · FDA Class III
Units
364 bags (1 mL filled in 2 mL glass amber vials; 20 vials shipped in a bag)
Sold at
Nationwide
Description
Subpotent: Failing Test Results for Epinephrine
Product
Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection Preservative Free NDC 71384-640-01 Not for resale. Office use only. Lot: 23APR018 Date Compounded: 24APR2023 Expires on: 17APR2024. In case of adverse event contact: www.fda.gov/medwatch or (800)-FDA-1088 Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ, 07852 (844) 446-6979
Manufacturer(s)
Imprimis NJOF, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →